Over 3000 patients have been treated at the Neutron Therapy Facility (NTF) since it opened on September 7, 1976. We are presently not accepting new patients but plan to resume operations in the future.

Neutrons are more effective at killing tumors than conventional radiation therapy. Cure rate depends on the type of cells in the tumor (histology), the size of the tumor (stage and/or grade), whether the tumor has spread to other parts of the body (metastasis), and the patient's general health.

Neutrons may be appropriate for the following sites, depending on stage and histology.(Click on link for more information about specific cancers.)

HEAD AND NECKSalivary glands, tongue, pharynx, oral cavity, nasopharynx
CHESTmediastinum, pleura, lung
ABDOMEN AND PELVISProstate, kidney, uterus
EXTREMITIES AND TRUNKSoft tissue, bone, cartilage
PALLIATIVELarge tumors and metastasis from neutron-sensitive tumors
The Neutron Therapy Facility at Fermilab is possible because of a unique alliance between the Fermi Research Alliance (FRA) and a medical provider. Fermilab is presently in the process of establishing a new partnership with a medical provider in order to resume the offering of neutron therapy.

Phone: 1-630-840-3865
FAX: 1-630-840-8766
e-mail: neutrons@fnal.gov

For general questions please contact neutrons@fnal.gov   For web questions, email kroc@fnal.gov   Or call 630-840-3865
Security, Privacy, LegalFermi National Accelerator Laboratory

Security, Privacy, Legal